BRNS - Barinthus Biotherapeutics PLC Qarzning balans kapitallashuviga nisbati
Barinthus Biotherapeutics (BRNS) kompaniyasining umumiy qarzdorlikning kapitalga nisbati vaktsinologiya va antiviral kurash sohasidagi brend nufuzini tasdiqlaydi, bunda ko'rsatkich 0.19 ga yetdi. Kompaniya kapital xarajatlarsiz royalti daromadlarini olish uchun o'z g'oyalarini sanoat gigantlariga patentlar sotish orqali monetizatsiya qilmoqda. Rivojlanishning joriy bosqichi yuqori R&D xarajatlarini qoplash uchun mavjud naqd pul rezervlaridan tizimli foydalanishga tayanadi.
%20Qarzning%20sof%20aktivlarga%20nisbati&width=1200&height=400&colorIndex=0&v=mvrk6wqv.ssk-7as46ww&start=20220704&end=20261028&filename=GURU_Markets_-_BRNS_-_Barinthus-Biotherapeutics_-_Debt-to-Net-Assets-Ratio "Barinthus Biotherapeutics - BRNS Qarzning balans kapitallashuviga nisbati (davr: 21.02.2024 - 19.09.2026) | 👁️GURU.Markets👁️")
Barinthus Biotherapeutics PLC (BRNS) kompaniyasi koʻrsatkichlari kesimi va tahlili
- narx va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi bo'yicha ma'lumotlar:
- balans kapitallashuvi bo'yicha ma'lumotlar:
- qarz va likvidlik bo'yicha ma'lumotlar:
Umumiy qarzning xususiy kapitalga nisbati Barinthus Biotherapeutics|BRNS - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Qisqa muddatli qarzning kapitalga nisbati Barinthus Bio|BRNS - Kompaniyaning umumiy qarz majburiyatlari|Qarzning balans kapitallashuviga nisbati Barinthus Biotherapeutics Corp|BRNS - Kompaniyaning uzoq muddatli majburiyatlari|Kompaniyaning qisqa muddatli qarzi Barinthus Biotherapeutics
Kompaniyaning jamlanma tahliliyoti:Barinthus Biotherapeutics (BRNS)
Umumiy majburiyatlarning kapitalga nisbati aktivlarni moliyalashtirish tuzilmasidagi qarz mablag‘larining ulushini o‘lchaydi. Ushbu ko‘rsatkich operatsion pul oqimi mavjud bo‘lmagan holatda moliyaviy barqarorlik darajasini va bankrotlik xavfini belgilaydi. Barinthus Biotherapeutics (BRNS) uchun yuqori R&D xarajatlari va klinik sinovlarga bog‘liqlik tufayli ushbu muvozanat juda muhimdir. Qarz mablag‘larini nazorat qilish dori vositalari tijoratlashtirilgunga qadar kapitalning kamayishining oldini oladi. Balans hisoboti kapitalizatsiyasidagi qarzlarning taqsimotini tahlil qilish orqali investor biznes modelining hayotiyligini baholashi mumkin.
Barinthus Biotherapeutics kimlar bilan raqobatlashadi
Balans kapitallashuviga qarzlar ARGX (argenx SE)|biontech.de - Balans kapitallashuviga qarzlar|Qarzning balans kapitallashuviga nisbati ABIVAX (ABVX)|ADMA: Qarzning sof aktivlarga nisbati|PTGX (Protagonist Therapeutics Inc) - Qarzning balans kapitallashuviga nisbati|Immunovant Therapeutics (IMVT) - Qarzning balans qiymatiga nisbati|KNSA (Kiniksa Pharmaceuticals) - Balans kapitallashuviga qarzlar|Balans kapitallashuviga qarzlar grifols.com (GRFS)|Adaptive Biotechnologies Corporation (ADPT) - Qarzning balans qiymatiga nisbati|Qarzning sof aktivlarga nisbati Celldex Therapeutics Inc (CLDX)|Balans kapitallashuviga qarzlar AUPH|BioCryst Corp - Sof aktivlarga qarzlar|VERA: Qarzning balans kapitallashuviga nisbati|DNTH: Qarzning balans qiymatiga nisbati|PHVS (Pharvaris) - Qarzning balans kapitallashuviga nisbati|Qarzning balans qiymatiga nisbati AbCellera Bio|TRML (Tourmaline Corp) - Qarzning balans qiymatiga nisbati|Balans kapitallashuviga qarzlar PGEN|Qarzning balans kapitallashuviga nisbati Pharming Group N.V. PHAR|Qarzning balans qiymatiga nisbati nektar.com (NKTR)|UPB: Balans kapitallashuviga qarzlar|Balans qiymatiga qarzlar Zenas Bio ZBIO|IMNM - Balans kapitallashuviga qarzlar|GOSS - Qarzning balans kapitallashuviga nisbati|KALV: Balans kapitallashuviga qarzlar|SEPN (septerna.com) - Balans kapitallashuviga qarzlar|PVLA - Qarzning balans kapitallashuviga nisbati|Qarzning sof aktivlarga nisbati Savara Inc|RIGL (Rigel Pharmaceuticals Inc) - Balans kapitallashuviga qarzlar|Sof aktivlarga qarzlar ANAB (AnaptysBio Inc.)|ATXS - Qarzning balans kapitallashuviga nisbati|ENGN - Qarzning balans qiymatiga nisbati|Qarzning balans qiymatiga nisbati RAPT Therapeutics, Inc. RAPT|JBIO - Qarzning balans kapitaliga nisbati|Balans kapitallashuviga qarzlar Aclaris ACRS|Qarzning sof aktivlarga nisbati Kyverna Therapeutics, Inc|TLSA (Tiziana Life Sciences) - Qarzning balans qiymatiga nisbati|Balans kapitallashuviga qarzlar CABA|VTYX (Ventyx Biosciences, Inc.) - Qarzning balans kapitallashuviga nisbati|Sof aktivlarga qarzlar Theratechnologies, Inc. THTX|Qarzning balans qiymatiga nisbati Avalo Therapeutics Inc.|Qarzning sof aktivlarga nisbati Eledon Pharmaceuticals, Inc ELDN|AGEN - Balans kapitallashuviga qarzlar|CLYM - Qarzning balans kapitallashuviga nisbati|Zura Bio Limited - Balans kapitallashuviga qarzlar|ATYR (aTyr Pharma Inc) - Sof aktivlarga qarzlar|Qarzning balans kapitallashuviga nisbati ADAG (Adagene Inc)|Balans qiymatiga qarzlar Ikena Oncology, Inc. (IMA)|Qarzning balans qiymatiga nisbati Shattuck Labs, Inc.|Qarzning balans kapitaliga nisbati equilliumbio.com (EQ)|Balans kapitallashuviga qarzlar Connect Biopharma Holdings Limited|Qarzning sof aktivlarga nisbati Immunic Therapeutics IMUX|ATRA (Atara Biotherapeutics Inc) - Balans kapitallashuviga qarzlar|IFRX: Balans qiymatiga qarzlar|Qarzning balans kapitallashuviga nisbati X4 Pharmaceuticals XFOR|Adicet Bio, Inc. (ACET) - Qarzning sof aktivlarga nisbati|CELU (Celularity Inc) - Balans kapitallashuviga qarzlar|Balans kapitallashuviga qarzlar INMB|KZR - Qarzning balans kapitallashuviga nisbati|Qarzlarning balans kapitallashuviga nisbati SAB Biotherapeutics Inc (SABS)|AKTX: Balans kapitallashuviga qarzlar|ENLV - Balans qiymatiga qarzlar|Q32 Bio Corp - Qarzning balans qiymatiga nisbati|GeoVax Labs (GOVX) - Balans kapitallashuviga qarzlar|EDSA - Qarzning balans qiymatiga nisbati|iBio Corporation (IBIO) - Qarzning balans kapitaliga nisbati|CARM: Balans kapitallashuviga qarzlar|Sof aktivlarga qarzlar xtlbio.com|Balans kapitallashuviga qarzlar BOLT (Bolt Biotherapeutics)|Qarzning balans qiymatiga nisbati HCWB (hcwbiologics.com)|Qarzning balans kapitallashuviga nisbati APVO|Sof aktivlarga qarzlar AIM ImmunoTech, Inc. AIM|ADTX - Balans kapitallashuviga qarzlar|GRI: Qarzning balans kapitallashuviga nisbati|Qarzning balans kapitallashuviga nisbati XORTX Therapeutics XRTX|HIND (Vyome Holdings Inc.) - Qarzning sof aktivlarga nisbati|Qarzning balans kapitallashuviga nisbati Revelation Bio (REVB)|Qarzning balans qiymatiga nisbati INDP|SCNI (Scinai Immunotherapeutics) - Qarzning balans kapitallashuviga nisbati|Sof aktivlarga qarzlar CALI (calcimedica.com)|Affimed N.V. (AFMD) - Qarzning balans kapitallashuviga nisbati|Qarzlarning balans kapitallashuviga nisbati Allakos Inc ALLK|Balans kapitallashuviga qarzlar HOOKIPA (HOOK)|IGMS - Qarzning sof aktivlarga nisbati|ITOS: Balans kapitallashuviga qarzlar|OCEA (oceanbiomedical.com) - Balans kapitallashuviga qarzlar|TCBP - Qarzning balans kapitallashuviga nisbati|Qarzning sof aktivlarga nisbati THRD